Creative Biolabs

Human iPSC-Derived Neural Stem Cells - Epilepsy Patient

[CAT#: NCL-2101-ZP11]

Species:
Human
Applications:
Cell Assay
Cell Types:
Neural Stem Cell

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Bulk Quote
Description
Creative Biolabs Human iPSC-Derived Neural Stem Cells (NSCs) are derived from integration-free, induced pluripotent stem cells (iPSCs) under fully defined neural induction conditions. The NSCs express typical markers of cerebral cortical neural stem and progenitor cells such as PAX6, FOXG1 and nestin, and spontaneously form polarized neural tube-like rosette structures when plated as a monolayer in culture (see below). Additionally, Creative Biolabs NSCs are capable of generating a spectrum of cerebral cortical excitatory and inhibitory neurons that are electrically active and have the ability to form functional synapses and circuits in vitro. After thawing and plating, the neural stem cells terminally differentiate to acquire mature electrophysiological properties, and form functional synaptic networks over a period of 40 ~ 50 days. Creative Biolabs NSCs are easy to differentiate to neurons or mixed neural cell types, following our protocols and using our tailored media and reagent bundles. A highly pure population of neurons can be generated from Creative Biolabs NSCs following the synchronous differentiation protocol. Using our specialized coating reagents, neurons derived from Creative Biolabs NSCs can be maintained in culture long-term (>1 year). NSCs are available from multiple donors to suit your research needs and have been characterized extensively.

Using our expertise in reprogramming and neural induction, Creative Biolabs has differentiated neural stem cells from iPSCs derived from a patient that was clinically diagnosed with epilepsy.
Cell Types
Neural Stem Cell
Applications
Cell Assay
Species
Human
Size
1.5 million cells & Neural Plating-XF Medium
Growth Pattern
Adherent
Tissue Source
Fibroblasts (5 Mo Female)
Cell Purity
>95%
Cell Viability
>90%
Mycoplasma Testing
The cell line has been screened using the luciferase based mycoplasma detection kit to confirm the absence of mycoplasma species.
Sterility Testing
Sterility testing was performed in accordance with USP and EP regulations. All of our sterility testing is performed in an isolator or clean room environments. The cell line has been screened using the membrane filtration testing methods to confirm the absence of aerobic, anaerobic and fungi microorganisms.
Genetic Stability Testing
Cell genetic stability study was perfomed under ICH guidelines. We provide guidance on the appropriate testing program upon your requirements.
Shipping
Dry ice
Storage
Liquid nitrogen
Handling Advice
Frozen cells:Upon receipt, frozen ampoules should be transferred directly to gaseous phase liquid nitrogen without delay, unless they are to be used straight away.

Growing cells: Growing cell cultures should be checked on receipt using an inverted microscope. Immediately check the cell density upon arrival for any obvious defects. If the cell density is too high (more than 80% confluent) subculture the cells (harvest and reseed) immediately.

For detailed instructions on the thawing procedure of frozen cells and the culture of adherent or suspended cells, please feel free to contact us by email or phone.
Research Use Only
For research use only, not for diagnostic or therapeutic use.
Warnings
Store under recommended storage conditions (liquid nitrogen). Do not expose to high temperature. After expiration, discard all remaining reagents. It is recommended to use cells within ten generations.
Quality Control
Each batch of cells has passed the high-level expression of Nestin and Sox 2 as well as its self-renewal and multi-lineage differentiation ability. The cells also showed normal karyotypes, and mycoplasma tests were negative by chromosome spread assessment. The blood of pregnant women has been screened for HIV, HTLV, hepatitis B and C.
Additional Donor Information
The patient presented with prenatal (3-4 weeks before delivery) tremors in utero. After birth, the patient exhibited bradycardia, abnormal EEG (central apneas present) and earlymy°Clonic encephalopathy. The patient's epilepsy was characterized further by: noted erratic seizures (1 to 5 per day), poor oral and motor skills, inability to follow with gaze and the brainstem auditory evoked response (BAER) revealed only waveforms I and III suggestive of upper pontine dysfunction. The donor was treated with phenobarbital and Klonopin.
For Research Use Only. Not For Clinical Use.
Send Inquiry Send Inquiry
Inquiry Basket
compare

Go to compare